Angiogenesis is central to cervical cancer development and progression, as it seems to be directly related to HPV inhibition of p53 and subsequent stabilization of hypoxia-inducible factor-one alpha (HIF-1 alpha), both of which increase the levels of vascular endothelial growth factor (VEGF) [59]. This evidence concerns the gene VEGFA and cervical carcinoma.